QIAGEN EBITDA Margin 2006-2021 | QGEN

Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for QIAGEN (QGEN) over the last 10 years. The current EBITDA margin for QIAGEN as of September 30, 2021 is .
QIAGEN EBITDA Margin Historical Data
Date TTM Revenue TTM EBITDA EBITDA Margin
2021-09-30 $2.24B $0.87B 38.75%
2021-06-30 $2.19B $0.78B 35.72%
2021-03-31 $2.07B $0.74B 35.64%
2020-12-31 $1.87B $0.64B 33.96%
2020-09-30 $1.71B $0.55B 32.36%
2020-06-30 $1.61B $0.31B 18.99%
2020-03-31 $1.55B $0.26B 16.77%
2019-12-31 $1.53B $0.25B 16.18%
2019-09-30 $1.52B $0.25B 16.61%
2019-06-30 $1.51B $0.53B 34.85%
2019-03-31 $1.51B $0.51B 33.97%
2018-12-31 $1.50B $0.51B 33.82%
2018-09-30 $1.50B $0.47B 31.08%
2018-06-30 $1.48B $0.45B 30.57%
2018-03-31 $1.45B $0.42B 28.89%
2017-12-31 $1.42B $0.40B 27.86%
2017-09-30 $1.39B $0.36B 25.65%
2017-06-30 $1.36B $0.34B 25.02%
2017-03-31 $1.35B $0.34B 25.52%
2016-12-31 $1.34B $0.33B 24.81%
2016-09-30 $1.32B $0.38B 28.86%
2016-06-30 $1.30B $0.38B 28.94%
2016-03-31 $1.28B $0.38B 29.43%
2015-12-31 $1.28B $0.39B 30.52%
2015-09-30 $1.29B $0.36B 28.17%
2015-06-30 $1.31B $0.37B 27.80%
2015-03-31 $1.33B $0.37B 28.15%
2014-12-31 $1.34B $0.38B 28.13%
2014-09-30 $1.35B $0.38B 28.10%
2014-06-30 $1.33B $0.36B 27.12%
2014-03-31 $1.32B $0.28B 21.22%
2013-12-31 $1.30B $0.26B 20.12%
2013-09-30 $1.29B $0.28B 21.51%
2013-06-30 $1.27B $0.28B 22.13%
2013-03-31 $1.26B $0.36B 28.53%
2012-12-31 $1.25B $0.37B 29.35%
2012-09-30 $1.24B $0.29B 23.53%
2012-06-30 $1.23B $0.28B 22.84%
2012-03-31 $1.20B $0.27B 22.56%
2011-12-31 $1.17B $0.27B 22.75%
2011-09-30 $1.12B $0.33B 29.26%
2011-06-30 $1.11B $0.30B 27.22%
2011-03-31 $1.09B $0.26B 23.83%
2010-12-31 $1.09B $0.26B 24.01%
2010-09-30 $1.09B $0.24B 22.11%
2010-06-30 $1.08B $0.24B 22.68%
2010-03-31 $1.05B $0.25B 23.93%
2009-12-31 $1.01B $0.24B 23.86%
2009-09-30 $0.96B $0.25B 25.89%
2009-06-30 $0.93B $0.26B 27.77%
2009-03-31 $0.91B $0.25B 27.45%
2008-12-31 $0.89B $0.25B 28.22%
2008-09-30 $0.87B $0.24B 27.94%
2008-06-30 $0.81B $0.23B 28.08%
2008-03-31 $0.73B $0.23B 31.28%
2007-12-31 $0.65B $0.20B 30.15%
2007-09-30 $0.57B $0.26B 45.23%
2007-06-30 $0.51B $0.24B 46.35%
2007-03-31 $0.49B $0.31B 63.09%
2006-12-31 $0.47B $0.38B 80.69%
2006-09-30 $0.44B $0.28B 62.16%
2006-06-30 $0.43B $0.27B 64.47%
2006-03-31 $0.41B $0.19B 44.90%
2005-12-31 $0.40B $0.10B 25.88%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $10.791B $1.870B
Qiagen NV produces biomedical and genetic products, products for separating and purifying nucleic acids for gene-based drug screening, nucleic acid-based clinical diagnostics, genetic vaccination and gene therapy.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $141.747B 8.96
Bio-Rad Laboratories (BIO.B) United States $17.038B 34.58
Biohaven Pharmaceutical Holding (BHVN) United States $7.896B 0.00
Emergent Biosolutions (EBS) United States $2.380B 8.56
Arcus Biosciences (RCUS) United States $2.057B 0.00
Myovant Sciences (MYOV) United Kingdom $1.157B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.011B 0.00
Zymeworks (ZYME) Canada $0.386B 0.00
Ambrx Biopharma (AMAM) United States $0.188B 0.00
SQZ Biotechnologies (SQZ) United States $0.178B 0.00
Enzo Biochem (ENZ) United States $0.154B 19.88